Tag: AskBio

Cell and Gene Therapy, Industry

AskBio’s Gene Therapy Gets Fast Track

July 21, 2021

Via: Contract Pharma

Asklepios BioPharmaceutical, Inc. (AskBio), a subsidiary of Bayer AG, was granted Fast Track Designation from the FDA for the LION-101 gene therapy program. LION-101 is a novel recombinant adeno-associated virus (rAAV) based vector being developed as a one-time intravenous infusion […]

Cell and Gene Therapy, Industry, Mergers and Acquisitions

Bayer to Pay up to $4B for Gene Therapy Firm AskBio

October 28, 2020

Via: Contract Pharma

Bayer AG has acquired Asklepios BioPharmaceutical, Inc. (AskBio) for $2 billion upfront and potential success-based milestone payments of up to $2 billion. The U.S.-headquartered biopharma specializes in the research, development and manufacturing of gene therapies across different therapeutic areas. AskBio’s […]